SMAD4 and laryngeal squamous cell carcinoma: In addition to that, Yan and colleagues described an oncogenic role for hsa-miR-301a-3p in Laryngeal Squamous Cell Carcinoma development through inhibition of Smad4 and participation in the EMT process [55].